We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+17.45%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$9.03B
AUM Growth
-$1.37B
Cap. Flow
-$2.48B
Cap. Flow %
-27.43%
Top 10 Hldgs %
18.31%
Holding
2,015
New
576
Increased
314
Reduced
307
Closed
636

Top Buys

Rank Stock Value
1
SKX
Skechers
SKX
+$18.3M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$17.4M
3
INSM icon
Insmed
INSM
+$16.1M
4
GILD icon
Gilead Sciences
GILD
+$15.8M
5
K
Kellanova
K
+$15.3M

Sector Composition

Rank Sector Weight
1 Healthcare 3.09%
2 Consumer Discretionary 2.5%
3 Technology 1.62%
4 Financials 1.05%
5 Communication Services 0.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACAD icon
1051
PUT
Acadia Pharmaceuticals
ACAD
$4.43B
$647K 0.01%
30,000
+10,000
+50% +$186K
BBWI icon
1052
Bath & Body Works
BBWI
$4.06B
$635K 0.01%
21,191
-5,332
-20% -$156K
KYMR icon
1053
PUT
Kymera Therapeutics
KYMR
$8.51B
$633K 0.01%
+14,500
New +$499K
ARWR icon
1054
PUT
Arrowhead Research
ARWR
$11.9B
$632K 0.01%
40,000
+15,000
+60% +$215K
NVAX icon
1055
PUT
Novavax
NVAX
$1.2B
$630K 0.01%
100,000
TTEK icon
1056
CALL
Tetra Tech
TTEK
$8.49B
$629K 0.01%
+17,500
New +$583K
BA icon
1057
Boeing
BA
$171B
$629K 0.01%
3,000
-6,800
-69% -$1.28M
CYTK icon
1058
Cytokinetics
CYTK
$10.5B
$628K 0.01%
19,000
-39,739
-68% -$1.38M
SABR icon
1059
Sabre
SABR
$731M
$624K 0.01%
197,600
+189,428
+2,318% +$486K
RNW icon
1060
CALL
ReNew
RNW
$2.27B
$622K 0.01%
90,000
-200,000
-69% -$1.31M
OXY icon
1061
CALL
Occidental Petroleum
OXY
$56.8B
$622K 0.01%
14,800
-100
-0.7% -$4.18K
FHN icon
1062
First Horizon
FHN
$12.2B
$621K 0.01%
29,287
+20,000
+215% +$381K
GTLB icon
1063
CALL
GitLab
GTLB
$5.83B
$609K 0.01%
+13,500
New +$617K
FND icon
1064
Floor & Decor
FND
$6.13B
$608K 0.01%
8,000
-71,300
-90% -$5.3M
PRTA icon
1065
PUT
Prothena Corp
PRTA
$425M
$607K 0.01%
+100,000
New +$751K
SYRE icon
1066
PUT
Spyre Therapeutics
SYRE
$8.54B
$599K 0.01%
+40,000
New +$592K
ADT icon
1067
CALL
ADT
ADT
$5.58B
$596K 0.01%
+70,400
New +$576K
DBRG icon
1068
DigitalBridge
DBRG
$2.93B
$593K 0.01%
+57,276
New +$546K
SNDK
1069
PUT
Sandisk
SNDK
$180B
$590K 0.01%
+13,000
New +$497K
GSAT icon
1070
PUT
Globalstar
GSAT
$10.7B
$589K 0.01%
25,000
-953,800
-97% -$19.2M
LNG icon
1071
Cheniere Energy
LNG
$55.2B
$584K 0.01%
2,400
-6,147
-72% -$1.42M
GPCR icon
1072
Structure Therapeutics
GPCR
$3.41B
$584K 0.01%
28,174
+18,918
+204% +$416K
NTR icon
1073
CALL
Nutrien
NTR
$33.2B
$582K 0.01%
+10,000
New +$565K
BNED icon
1074
Barnes & Noble Education
BNED
$431M
$580K 0.01%
49,318
+38,595
+360% +$412K
EWZ icon
1075
iShares MSCI Brazil ETF
EWZ
$9.28B
$577K 0.01%
+20,000
New +$540K

Similar funds

Caption Management's Q2 2025 Portfolio in Review

As of Q2 2025, Caption Management held 2,015 positions worth $9.03B, down 13% from $10.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Caption Management withdrew a net $2.48B in Q2 2025, closing 636 positions and reducing 307 holdings. Its most notable exit was Microsoft, an estimated $394M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 1.5% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Caption Management opened a new position in Skechers worth $20.1M.

  • Caption Management's largest Q2 2025 buy was Skechers: 317,932 shares worth $20.1M.
  • Caption Management added most to Kellanova in Q2 2025, an estimated $15.3M increase.
  • Caption Management's biggest Q2 2025 reduction was Alphabet (Google) Class A, cutting an estimated $121M.
  • Caption Management fully exited Microsoft in Q2 2025, selling an estimated $394M.
  • Caption Management's ten largest holdings make up 18% of its $9.03B portfolio in Q2 2025.
  • Caption Management opened 576 new positions and closed 636 in Q2 2025.
  • Caption Management's portfolio value fell 13% quarter-over-quarter to $9.03B.

Based on Caption Management's 13F filing for Q2 2025, filed 14 Aug 2025.